AB Science S.A. (ABSCF)
USD 0.89
(0.0%)
USD 0.89
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -17.14 Million | -17.47 Million | -17.17 Million | -13.51 Million | -15.15 Million | -26.79 Million |
| Net Income | -10.04 Million | -13.61 Million | -14.46 Million | -15.04 Million | -21.74 Million | -26.06 Million |
| Depreciation & Amortization | 990 Thousand | -81 Thousand | 1.73 Million | 1.14 Million | 1.07 Million | 923 Thousand |
| Deferred income taxes | - | 4000.00 | 36 Thousand | - | - | 1000.00 |
| Stock-based compensation | 605 Thousand | 133 Thousand | 258 Thousand | 95 Thousand | 119 Thousand | 149 Thousand |
| Change in working capital | -4.42 Million | -2.83 Million | -5.55 Million | 180 Thousand | 1.53 Million | 1.03 Million |
| Other non-cash items | -1.67 Million | -1.08 Million | 816 Thousand | 112 Thousand | 3.86 Million | -2.84 Million |
| Investing Cash Flow | -345 Thousand | -360 Thousand | -590 Thousand | -277 Thousand | -432 Thousand | -490 Thousand |
| Investments in PPE | -345 Thousand | -644 Thousand | -564 Thousand | -370 Thousand | -390 Thousand | -484 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -269 Thousand | 284 Thousand | -26 Thousand | 93 Thousand | -42 Thousand | -6000.00 |
| Financing Cash Flow | 16.27 Million | 16.39 Million | 5.84 Million | 28.73 Million | 9.73 Million | 61 Thousand |
| Debt repayment | -4.8 Million | -188 Thousand | -4.31 Million | -6000.00 | -2.2 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 11.47 Million | 4000.00 | 4.15 Million | 22.67 Million | 9.74 Million | 61 Thousand |
| Other Financing Activities | -1000.00 | 16.57 Million | 6 Million | 6.06 Million | 2.19 Million | 61 Thousand |
| Accounts receivables | -75 Thousand | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 120 Thousand | - | - | - | - | - |
| Other working capital | -4.41 Million | -2.83 Million | -5.55 Million | 180 Thousand | 1.53 Million | 1.03 Million |
| Cash at beginning of period | 7.26 Million | 8.72 Million | 20.66 Million | 5.69 Million | 11.56 Million | 38.78 Million |
| Cash at end of period | 6.06 Million | 7.26 Million | 8.72 Million | 20.66 Million | 5.69 Million | 11.56 Million |
| Capital Expenditure | -345 Thousand | -644 Thousand | -564 Thousand | -370 Thousand | -390 Thousand | -484 Thousand |
| Effect of forex changes on cash | 8000.00 | -11 Thousand | -14 Thousand | 19 Thousand | -10 Thousand | -7000.00 |
| Net cash flow / Change in cash | -1.2 Million | -1.45 Million | -11.93 Million | 14.96 Million | -5.86 Million | -27.22 Million |
| Free Cash Flow | -17.48 Million | -18.11 Million | -17.74 Million | -13.88 Million | -15.54 Million | -27.27 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.23 Million | -2.23 Million | -10.04 Million | -787 Thousand | -787 Thousand | -10.41 Million |
| Depreciation & Amortization | 99.5 Thousand | 99.5 Thousand | 990 Thousand | -161.5 Thousand | -161.5 Thousand | 1.31 Million |
| Deferred income taxes | - | - | - | - | - | -2.89 Million |
| Stock-based compensation | - | - | 605 Thousand | 31 Thousand | 31 Thousand | 271.5 Thousand |
| Change in working capital | 3.33 Million | 3.33 Million | -4.42 Million | -1.05 Million | -1.05 Million | -2.1 Million |
| Other non-cash items | 458 Thousand | 458 Thousand | -1.67 Million | -1.81 Million | -1.81 Million | 4.45 Million |
| Investing Cash Flow | -39.5 Thousand | -39.5 Thousand | -345 Thousand | -184.5 Thousand | -184.5 Thousand | -185 Thousand |
| Investments in PPE | -45.5 Thousand | -45.5 Thousand | -345 Thousand | -80 Thousand | -80 Thousand | -185 Thousand |
| Acquisitions | 6000.00 | 6000.00 | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -269 Thousand | -104.5 Thousand | -104.5 Thousand | -30 Thousand |
| Financing Cash Flow | -87.5 Thousand | -87.5 Thousand | 16.27 Million | -396 Thousand | -396 Thousand | 17.06 Million |
| Debt repayment | - | - | -4.8 Million | -807 Thousand | - | -5.6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 11.47 Million | 15 Thousand | - | 11.45 Million |
| Other Financing Activities | -87.5 Thousand | -87.5 Thousand | -1000.00 | -396 Thousand | -396 Thousand | 8.53 Million |
| Accounts receivables | - | - | -75 Thousand | -80.75 Thousand | -80.75 Thousand | 43.25 Thousand |
| Accounts payables | - | - | - | - | - | -965.99 Thousand |
| Inventory | - | - | 120 Thousand | 32.94 Thousand | 32.94 Thousand | 27.05 Thousand |
| Other working capital | 3.33 Million | 3.33 Million | -4.41 Million | -1 Million | -1 Million | -1.2 Million |
| Cash at beginning of period | - | - | 7.26 Million | 14.78 Million | - | 7.26 Million |
| Cash at end of period | 1.53 Million | 1.53 Million | 6.06 Million | 6.06 Million | -4.36 Million | 14.78 Million |
| Capital Expenditure | -45.5 Thousand | -45.5 Thousand | -345 Thousand | -80 Thousand | -80 Thousand | -185 Thousand |
| Effect of forex changes on cash | -2500.00 | -2500.00 | 8000.00 | 2000.00 | 2000.00 | 2000.00 |
| Net cash flow / Change in cash | 1.53 Million | 1.53 Million | -1.2 Million | -8.72 Million | -4.36 Million | 7.51 Million |
| Free Cash Flow | 1.61 Million | 1.61 Million | -17.48 Million | -3.86 Million | -3.86 Million | -9.55 Million |
EOG
UBXG
ZUARIIND
3338
MS-PA
BYYLF